ELLIE EBREO: Open Payments
NPI 1164466140 · PHARR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,556 in 24 payments from 16 companies in 2025. Trend: 2023 $516 · 2024 $1,011 · 2025 $1,556
Food & beverage: $1,457Education: $99
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 1 | $142 |
| Boston Scientific Corporation | 1 | $138 |
| Astellas Pharma US Inc | 3 | $132 |
| Corcept Therapeutics | 1 | $125 |
| Ascensia Diabetes Care Us Inc. | 2 | $123 |
| Phathom Pharmaceuticals, Inc. | 1 | $120 |
| Lilly USA, LLC | 1 | $115 |
| Biogen, Inc. | 1 | $115 |
| Dexcom, Inc. | 1 | $108 |
| Madrigal Pharmaceuticals | 1 | $98 |
Products named: Barostim Neo System, ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter, ZURZUVAE, Korlym, VOQUEZNA, ZEPBOUND, DEXCOM G7 GSS (161), REZDIFFRA.
Industry payments across TX — which companies pay providers there.
